The store will not work correctly when cookies are disabled.
(R)-6-chloro-3-(1-phenylethyl)amino-4H-thieno[3,2-e]-1,2,4-thiadiazine1,1-dioxide
ID: ALA208928
PubChem CID: 135443399
Max Phase: Preclinical
Molecular Formula: C13H12ClN3O2S2
Molecular Weight: 341.85
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: C[C@@H](NC1=NS(=O)(=O)c2sc(Cl)cc2N1)c1ccccc1
Standard InChI: InChI=1S/C13H12ClN3O2S2/c1-8(9-5-3-2-4-6-9)15-13-16-10-7-11(14)20-12(10)21(18,19)17-13/h2-8H,1H3,(H2,15,16,17)/t8-/m1/s1
Standard InChI Key: ZAUMBMUESRLSEO-MRVPVSSYSA-N
Molfile:
RDKit 2D
21 23 0 0 1 0 0 0 0 0999 V2000
-1.3643 -20.2054 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
-0.6518 -19.7991 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-0.6518 -18.9741 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.3643 -18.5555 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-2.8615 -20.0514 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
-2.0769 -19.7991 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.0769 -18.9741 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.8623 -18.7176 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.3426 -19.3875 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.7835 -20.7899 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-1.9526 -20.7899 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
0.0644 -18.5617 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-4.1676 -19.3896 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
0.7781 -18.9783 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.4944 -18.5658 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.2049 -18.9861 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.9164 -18.5743 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.9193 -17.7485 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.2047 -17.3361 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.4919 -17.7461 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.7757 -19.8033 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 10 2 0
6 7 2 0
1 11 2 0
3 12 1 0
7 4 1 0
9 13 1 0
6 1 1 0
12 14 1 0
1 2 1 0
14 15 1 0
2 3 2 0
15 16 2 0
5 6 1 0
16 17 1 0
7 8 1 0
17 18 2 0
8 9 2 0
18 19 1 0
9 5 1 0
19 20 2 0
20 15 1 0
3 4 1 0
14 21 1 1
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 341.85 | Molecular Weight (Monoisotopic): 341.0059 | AlogP: 3.22 | #Rotatable Bonds: 2 |
Polar Surface Area: 70.56 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 13.03 | CX Basic pKa: 1.40 | CX LogP: 3.26 | CX LogD: 3.26 |
Aromatic Rings: 2 | Heavy Atoms: 21 | QED Weighted: 0.88 | Np Likeness Score: -1.24 |
References
1. Nielsen FE, Ebdrup S, Jensen AF, Ynddal L, Bodvarsdottir TB, Stidsen C, Worsaae A, Boonen HC, Arkhammar PO, Fremming T, Wahl P, Kornø HT, Hansen JB.. (2006) New 3-alkylamino-4H-thieno-1,2,4-thiadiazine 1,1-dioxide derivatives activate ATP-sensitive potassium channels of pancreatic beta cells., 49 (14): [PMID:16821773] [10.1021/jm060042j] |